Lack of Benefit for Intravenous Thrombolysis in Patients With Myocardial Infarction Who Are Older Than 75 Years

2000319 citationsReviewbronze Open Access

Authors

David R. Thiemann · Johns Hopkins University

Josef Coresh · Johns Hopkins University

Steven P. Schulman · Johns Hopkins University

Gary Gerstenblith · Johns Hopkins University

William J. Oetgen · Johns Hopkins University

Neil R. Powe · Johns Hopkins University

Abstract

In nationwide clinical practice, thrombolytic therapy for patients >75 years old is unlikely to confer survival benefit and may have a significant survival disadvantage. Reperfusion research that is focused on elderly patients is urgently needed.

Topics & Keywords

Acute Myocardial Infarction Research Heart Failure Treatment and Management Coronary Interventions and Diagnostics

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Circulation

Volume 101, Issue 19, pp. 2239-2246

DOI: 10.1161/01.cir.101.19.2239

Field-Weighted Citation Impact: 27.23